Medical Services

How Accurate is CXL Eye Surgery?

Keratoconus is a progressive eye condition that develops in 1 in 1,000 people and often begins in adolescence or early adulthood. Keratoconus distorts vision because the cornea, which is normally round, begins to thin and deform into a conical shape.

With a Keratoconusissue your vision perhaps looks like blurry

Blurry vision caused by keratoconus is different from blurry vision which is caused by other common refractive errors, such as near-sightedness or hyperopia. In the advanced stages of keratoconus, it can be difficult to achieve satisfactory vision, even with glasses or contact lenses. Kraff eye institute offers two effective ways to treat keratoconus.

Corneal collagen crosslinking

The first treatment is the cross-linking of corneal collagen, also known by the acronym CXL. This non-invasive procedure strengthens the cornea by “cross-linking” the collagen fibers of the cornea through the instillation of riboflavin and exposure to UVA rays. It is the only proven treatment for keratoconus that can slow or slow the progression of the disease.

Corneal collagen crosslinking + topography-guided KPR

CXL alone does not improve vision. Kraff eye institute is one of the few centers that offers the sophisticated corneal Cross-Linking+ T-KPR procedure. This dual treatment combines the benefits of CXL and topography-guided KPR laser intervention, hence the name CXL + T-KPR. This laser treatment allows patients with keratoconus to have better visual acuity.

The goal of treatment is to strengthen the collagen fibers that make up the cornea, to prevent their deformation. This treatment is performed in the operating room and lasts, depending on the technique, up to an hour. After preparation of the surface of the cornea, it is soaked with drops of riboflavin (= vitamin B2). Then the cornea is exposed to very localize ultraviolet radiation. A contact lens dressing is then applied to the eye for a few days.